TO migrate in the vessel wall, smooth muscle cells (SMCs) must contend with
abundant type I collagen. We investigated: the mechanisms used by human SM
Cs to efficiently migrate on type I collagen, following stimulation with fi
broblast growth factor-2 (FGF-2). FGF-a-stimulated migration was inhibited
by a hydroxamic acid inhibitor of matrix metalloproteinases and by a neutra
lizing anti-collagenase-1 antibody. Moreover, migration speed of SMCs plate
d on mutant collagenase-resistant type I collagen was not increased by FGF-
S. Time-lapse video analysis of unstimulated SMCs migrating on collagen rev
ealed discrete phases of leading edge membrane extension and rear retractio
n, the latter often after rupture of an elongated tail. FGF-2 stimulation y
ielded a more synchronous, gliding motion with a collagenase-1-mediated dec
rease in tail ripping. Surface labeling of SMCs with biotin followed by imm
unoprecipitation revealed that a proportion of active collagenase-1, expres
sed in response to FGF-2, was bound to the plasma membrane. Pericellular co
llagen substrate cleavage-was verified by immunostaining for neoepitopes ge
nerated by collagenase-1 action and was localized to discrete zones beneath
the cell tail and the leading edge. These results identify a novel mechani
sm by which SMC migration on collagen is enhanced, whereby rear release fro
m the substrate is orchestrated by the localized actions of membrane-bound
collagenase-1.